SCHEMBL894974

SCHEMBL894974

Cc1ccc(-c2ccccc2O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.65
HPGD P15428 4/20 0.65
HSD17B10 Q99714 3/20 0.65
BCL2L1 Q07817 1/20 0.65
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
POLB P06746 3/20 0.48
KDM1A O60341 1/20 0.48
ESR2 Q92731 1/20 0.48
BACE1 P56817 2/20 0.46
COMT P21964 1/20 0.44
MMP12 P39900 1/20 0.43
MMP13 P45452 1/20 0.43
APP P05067 1/20 0.43
MAPT P10636 5/20 0.42
LMNA P02545 4/20 0.42
KDM4E B2RXH2 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
NPC1 O15118 2/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29360137 1.00 ALDH1A1 (0.65) ALDH1A1HPGDHSD17B10BCL2L1MEN1
Hydrogen Sulfide SCHEMBL27658263 0.98 ALDH1A1 (0.62) ALDH1A1HPGDHSD17B10BCL2L1MEN1
Orthocresol SCHEMBL11312171 0.92 HPGD (0.56) ALDH1A1HPGDHSD17B10BCL2L1MEN1
SCHEMBL20721747 0.91 ALDH1A1 (0.54) ALDH1A1HPGDHSD17B10BCL2L1MEN1
SCHEMBL714236 0.87 ALDH1A1 (0.83) ALDH1A1HPGDHSD17B10BCL2L1POLB
SCHEMBL29443997 0.87 ALDH1A1 (0.83) ALDH1A1HPGDHSD17B10BCL2L1POLB
SCHEMBL6049406 0.87 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10BCL2L1MEN1
SCHEMBL17759046 0.86 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10BCL2L1MEN1
Phthalic Acid SCHEMBL28383282 0.85 AKR1C3 (0.54) ALDH1A1HPGDHSD17B10BCL2L1KMT2A
SCHEMBL18189724 0.85 ALDH1A1 (0.79) ALDH1A1HPGDHSD17B10BCL2L1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115028763-A Cycloolefin copolymer and preparation method thereof 中国科学院长春应用化学研究所 2022-09-09 CN claimed
US-7396895-B2 Branched polyarylene ethers and processes for the preparation thereof XEROX CORPORATION (US) 2008-07-08 US claimed
US-7067608-B2 Process for preparing branched polyarylene ethers XEROX CORPORATION (US) 2006-06-27 US claimed
US-20050208416-A1 Branched polyarylene ethers and processes for the preparation thereof XEROX CORPORATION 2005-09-22 US claimed
US-20050154178-A1 Process for preparing branched polyarylene ethers XEROX CORPORATION 2005-07-14 US claimed
EP-0224116-B1 A METHOD FOR PRODUCING CYCLOALKANOLS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-11-27 EP claimed
US-4716253-A ACID CATALYZED HYDRATION OF CYCLOALKENE IN PRESENCE OF PHENOL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-12-29 US claimed
EP-0224116-A2 A method for producing cycloalkanols SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-06-03 EP claimed
US-12503480-B2 Cyclic phosphazene compound having oxaphosphorin ring-containing structure FUSHIMI PHARMACEUTICAL CO., LTD. (JP) 2025-12-23 US disclosed
CN-119948080-A Active ester resin, epoxy resin composition, cured product thereof, prepreg, laminated board and laminated film 日铁化学材料株式会社 2025-05-06 CN disclosed
CN-119403857-A Multifunctional vinyl resin and method for producing same 日铁化学材料株式会社 2025-02-07 CN disclosed
CN-118599090-A Vinyl resin production method, vinyl resin, composition thereof, cured product, prepreg, resin sheet, and laminate 日铁化学材料株式会社 2024-09-06 CN disclosed
CN-118515536-A Preparation process of low-cost p-phenoxy phenol 程冬冬 2024-08-20 CN disclosed
WO-2024106209-A1 POLYFUNCTIONAL VINYL RESIN, MANUFACTURING METHOD THEREFOR, POLYFUNCTIONAL VINYL RESIN COMPOSITION, AND CURED PRODUCT THEREOF 日鉄ケミカル&マテリアル株式会社 2024-05-23 WO disclosed
US-4043970-A IMPROVED CURE RATE IN ELECTRICAL LAMINATES MONSANTO COMPANY (US) 1977-08-23 US disclosed
US-4022942-A NOVOLAKS OR B-STAGE RESINS MONSANTO COMPANY (US) 1977-05-10 US disclosed
US-3974229-A ALKYLATION CATALYSTS GENERAL ELECTRIC COMPANY (US) 1976-08-10 US disclosed
US-3972836-A MAGNESIUM OXIDE-MANGANESE OXIDE CATALYST GENERAL ELECTRIC COMPANY (US) 1976-08-03 US disclosed
US-3947468-A Production of dibenzopyrans, their isomeric fluorenols and dibenzothiopyrans GENERAL ELECTRIC COMPANY (US) 1976-03-30 US disclosed
US-3937669-A VANADIUM OXIDE ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) 1976-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503480-B2 Cyclic phosphazene compound having oxaphosphorin ring-containing structure PFAS, PHOSPHO1, PAF1 ALDH1A1 1437/4885HPGD 2691/4885HSD17B10 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.